The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

Historians tell us that the first Thanksgiving happened a little over 400 years ago. It was a much different experience than what we practice today with our traditions. In fact, ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...